 |
市場調查報告書
商品編碼
1616095
2024年至2032年獸醫立體定位放射外科系統市場機會、成長動力、產業趨勢分析與預測Veterinary Stereotactic Radiosurgery System Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032 |
||||||
2023 年，全球獸醫立體定位放射外科系統市場價值為 4.123 億美元，預計 2024 年至 2032 年複合年成長率為 9.3%。診斷和治療技術的創新，例如人工智慧驅動的系統和先進的放射療法，提高了獸醫腫瘤學的精確度和有效性。這推動了對先進系統的需求。寵物主人和獸醫診所尋求癌症管理的創新解決方案，刺激了對專業設備和服務的需求。
市場分為線性加速器（直線加速器）、射波刀和伽馬刀。 2023 年，直線加速器部門的收入為 1.993 億美元。直線加速器系統擅長為各種腫瘤（包括腦腫瘤和脊椎腫瘤）提供標靶放射治療。先進的影像和治療功能使直線加速器系統成為各種獸醫腫瘤學應用的理想選擇。
在經過驗證的有效性和持續的技術進步的推動下，它們在獸醫醫院和專科診所中得到廣泛採用，鞏固了直線加速器領域在市場上的領先地位。根據應用，獸醫立體定位放射手術系統市場分為腦腫瘤、脊椎腫瘤和其他應用。 2023 年，腦腫瘤細分市場佔據 59% 的主導市場佔有率，預計這一趨勢將在整個分析期間持續存在。利用立體定位放射外科系統治療這些腫瘤可確保精確、非侵入性的治療方法，從而顯著減少對鄰近健康組織的傷害。
| 市場範圍 | |
|---|---|
| 開始年份 | 2023年 |
| 預測年份 | 2024-2032 |
| 起始值 | 4.123 億美元 |
| 預測值 | 9.12 億美元 |
| 複合年成長率 | 9.3% |
獸醫實務中腦腫瘤的高發生率凸顯了對專門用於治療這些腫瘤的先進立體定位放射手術技術的需求。 2023年，美國以1.52億美元的估值引領北美獸醫立體定位放射外科系統市場。美國的主導地位源自於其最先進的獸醫醫療基礎設施和對創新技術的迅速採用。美國許多專業獸醫醫院和研究機構利用立體定位放射外科系統來解決寵物的複雜癌症病例。
主要技術提供者的存在和獸醫腫瘤學領域的持續創新鞏固了美國市場的領導地位。高寵物擁有率和投資先進治療的意願進一步推動了這項需求。
目錄
第 1 章：方法與範圍
第 2 章：執行摘要
第 3 章：產業洞察
- 產業生態系統分析
- 產業影響力
- 成長動力
- 增加動物數量和擁有率
- 動物癌症發生率上升
- 癌症診斷和治療技術的進步
- 提高早期診斷和治療意識
- 產業陷阱與挑戰
- 治療費用高
- 立體定位放射外科系統的稀缺
- 嚴格的監管標準和核准程序
- 成長動力
- 成長潛力分析
- 監管環境
- 波特的分析
- PESTEL分析
第 4 章：競爭格局
- 介紹
- 公司矩陣分析
- 主要市場參與者的競爭分析
- 競爭定位矩陣
- 戰略儀表板
第 5 章：市場估計與預測：按產品分類，2021 - 2032 年
- 主要趨勢
- 直線加速器（Linac）
- 射波刀
- 伽瑪刀
第 6 章：市場估計與預測：按應用分類，2021 - 2032
- 主要趨勢
- 腦腫瘤
- 脊椎腫瘤
- 其他應用
第 7 章：市場估計與預測：按最終用戶分類，2021 - 2032 年
- 主要趨勢
- 獸醫院
- 獸醫診所
- 其他最終用戶
第 8 章：市場估計與預測：按地區分類，2021 - 2032 年
- 主要趨勢
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
- 亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
- 拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
- 中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區
第 9 章：公司簡介
- Accuray Incorporated
- Elekta AB
- Varian Medical Systems
The Global Veterinary Stereotactic Radiosurgery System Market was valued at USD 412.3 million in 2023 and is projected to grow at a CAGR of 9.3% from 2024 to 2032. Drivers include the increasing focus on advancing cancer care and research for animals. Innovations in diagnostic and treatment technologies, such as AI-driven systems and advanced radiation therapies, enhance the precision and effectiveness of veterinary oncology. This propels the demand for advanced systems. Pet owners and veterinary practices seek innovative solutions for cancer management, fueling the demand for specialized equipment and services.
The market is segmented into linear accelerators (Linac), CyberKnife, and gamma knife. In 2023, the Linac segment generated revenue of USD 199.3 million. Linac systems excel in delivering targeted radiation therapy for various tumors, including brain and spinal tumors. Advanced imaging and treatment capabilities make Linac systems ideal for a wide range of veterinary oncology applications.
Their widespread adoption in veterinary hospitals and specialty clinics, driven by proven effectiveness and ongoing technological advancements, solidifies the Linac segment's top position in the market. Based on application, the veterinary stereotactic radiosurgery system market is categorized into brain tumors, spinal tumors, and other applications. In 2023, the brain tumors segment commanded a dominant market share of 59%, a trend anticipated to persist throughout the analysis period. Utilizing the stereotactic radiosurgery system for these tumors ensures a precise, non-invasive treatment approach, significantly reducing harm to adjacent healthy tissues.
| Market Scope | |
|---|---|
| Start Year | 2023 |
| Forecast Year | 2024-2032 |
| Start Value | $412.3 Million |
| Forecast Value | $912 Million |
| CAGR | 9.3% |
The high incidence of brain tumors in veterinary practices underscores the demand for advanced stereotactic radiosurgery technologies, tailored specifically for managing these tumors. In 2023, the U.S. led the North American veterinary stereotactic radiosurgery system market with a valuation of USD 152 million. The U.S. dominance stems from its state-of-the-art veterinary healthcare infrastructure and a swift embrace of innovative technologies. Numerous specialized veterinary hospitals and research institutions in the U.S. leverage stereotactic radiosurgery systems to address intricate cancer cases in pets.
The presence of major technology providers and ongoing innovations in veterinary oncology bolster the U.S. market leadership. High rates of pet ownership and a readiness to invest in advanced treatments further fuel this demand.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing animal population and ownership rates
- 3.2.1.2 Rising cancer incidences among animals
- 3.2.1.3 Advancements in technology for diagnosing and treating cancer
- 3.2.1.4 Heightened awareness regarding early diagnosis and treatment
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 High treatment costs
- 3.2.2.2 Scarcity of stereotactic radiosurgery systems
- 3.2.2.3 Stringent regulatory standards and approval procedures
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Porter's analysis
- 3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Competitive analysis of major market players
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Linear accelerators (Linac)
- 5.3 CyberKnife
- 5.4 Gamma knife
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Brain tumors
- 6.3 Spinal tumors
- 6.4 Other applications
Chapter 7 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Veterinary hospitals
- 7.3 Veterinary clinics
- 7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 Accuray Incorporated
- 9.2 Elekta AB
- 9.3 Varian Medical Systems
